The new standard in GCP training is available now — and it’s free for ACRP Members.
Learn More
A second U.S. Food and Drug Administration (FDA) Warning Letter has been issued to a firm for alleged ClinicalTrials.gov reporting noncompliance violations. Georgia-based Accuitis, Inc. could be “subject to a civil monetary penalty of not more than $10,000 for each day of the violation” until the noncompliance is corrected, the FDA says in […]
The use of digital health technologies across healthcare and drug development has accelerated. A new paper in the Journal of Parkinson’s Disease titled “Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective,” coauthored by experts across diverse disciplines, highlights how new remote monitoring technologies present a tremendous opportunity to advance digital medicine […]
In order to win the battle against COVID-19, studies to develop vaccines, drugs, devices, and re-purposed drugs are urgently needed. Randomized clinical trials are used to provide evidence of safety and efficacy as well as to better understand this novel and evolving virus. As of July 15, more than 6,180 COVID-19 clinical trials have been […]
Mitigate risk and improve regulatory compliance with insider advice from FDA officials and industry experts.
RegisterJoin Advarra to learn how implementing eRegulatory & eConsent systems can improve compliance and productivity, and reduce cost, and identify opportunities for research programs to advance the way they do research in a changing environment.
Register